ClinicalTrials.Veeva

Menu

Bone Pain Score Validation Initiative (ARIE)

iOMEDICO logo

iOMEDICO

Status

Completed

Conditions

Bone Metastasis

Study type

Observational

Funder types

Industry

Identifiers

NCT02293642
IOM-268

Details and patient eligibility

About

Translation and validation of the BOMET-QoL-10 questionnaire in Germany and assessment of its validity and responsiveness.

Full description

Aim of this study is to translate the questionnaire and to examine the psychometric properties of BOMET-QoL-10 in a German population. Correlations with the EORTC QLQ-C30/BM22 at the time of enrolment and throughout the study aim to verify that the BOMET-QoL-10 is reliable, valid and able to detect stabilization or changes in quality of life.

Enrollment

370 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Male or female adults patients (≥ 18 years)
  • Diagnosed cancer of the breast, kidney, lung or prostate
  • Bone metastases
  • Estimated life expectancy of at least 6 months
  • Fluent German speaking, reading and writing
  • Informed written consent

Exclusion criteria

  • Patients without bone metastases
  • Participation in another study involving questionnaires
  • Patients not able to comply with the assessments specified in the protocol

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems